Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The Novel Histone Deacetylase Inhibitor RAS2410 (Resminostat) Interferes with Important Signalling Pathways and Induces Apoptosis in Multiple Myeloma Cells.

Philipp Baumann, Sonja Mandl-Weber, Felix Meinel, Ruediger Jankowsky, Fuat S. Oduncu, Ralf Schmidmaier

Blood (2009) 114 (22): 4928.

https://doi.org/10.1182/blood.V114.22.4928.4928

Published: 2009

Journal Articles

The Novel NFkB Inhibitor V1810 Induces Apoptosis and Cell Cycle Arrest in Multiple Myeloma Cells and Overcomes NFkB Mediated Drug Resistance.

Felix Meinel, Sonja Mandl-Weber, Philipp Baumann, Johann Leban, Ralf Schmidmaier

Blood (2008) 112 (11): 1715.

https://doi.org/10.1182/blood.V112.11.1715.1715

Published: 2008

Journal Articles

S-2209, a Novel, Non-Boronic Proteasome Inhibitor, Induces Apoptosis and Cell Growth Arrest in Multiple Myeloma Cells.

Philipp Baumann, Karin Mueller, Sonja Mandl-Weber, Helmut Ostermann, Ralf Schmidmaier, Fuat Oduncu, Johann Leban, Robert Doblhofer, Astrid Ammendola, Roland Baumgartner

Blood (2007) 110 (11): 1513.

https://doi.org/10.1182/blood.V110.11.1513.1513

Published: 2007

Journal Articles

Myeloma Cell Proliferation Is Inhibitied by the Activation of Adenosine Monophosphate Activated Protein Kinase (AMPK).

Philipp Baumann, Sonja Mandl-Weber, Bertold Emmerich, Christian Straka, Daniel Franke, Ralf Schmidmaier

Blood (2006) 108 (11): 5045.

https://doi.org/10.1182/blood.V108.11.5045.5045

Published: 2006

Journal Articles

Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels

Katja Specht, Eugenia Haralambieva, Karin Bink, Marcus Kremer, Sonja Mandl-Weber, Ina Koch, Raju Tomer, Heinz Hofler, Ed Schuuring, Philip M. Kluin, Falko Fend, Leticia Quintanilla-Martinez

Blood (2004) 104 (4): 1120–1126.

https://doi.org/10.1182/blood-2003-11-3837

Published: 2004

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

The Novel Histone Deacetylase Inhibitor RAS2410 (Resminostat) Interferes with Important Signalling Pathways and Induces Apoptosis in Multiple Myeloma Cells.

The Novel NFkB Inhibitor V1810 Induces Apoptosis and Cell Cycle Arrest in Multiple Myeloma Cells and Overcomes NFkB Mediated Drug Resistance.

S-2209, a Novel, Non-Boronic Proteasome Inhibitor, Induces Apoptosis and Cell Growth Arrest in Multiple Myeloma Cells.

Myeloma Cell Proliferation Is Inhibitied by the Activation of Adenosine Monophosphate Activated Protein Kinase (AMPK).

Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels

Email alerts

ASH Publications

American Society of Hematology

Update search

The Novel Histone Deacetylase Inhibitor RAS2410 (Resminostat) Interferes with Important Signalling Pathways and Induces Apoptosis in Multiple Myeloma Cells.

The Novel NFkB Inhibitor V1810 Induces Apoptosis and Cell Cycle Arrest in Multiple Myeloma Cells and Overcomes NFkB Mediated Drug Resistance.

S-2209, a Novel, Non-Boronic Proteasome Inhibitor, Induces Apoptosis and Cell Growth Arrest in Multiple Myeloma Cells.

Myeloma Cell Proliferation Is Inhibitied by the Activation of Adenosine Monophosphate Activated Protein Kinase (AMPK).

Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only